Parathyroid Hormone as a Functional Indicator of Vitamin D Sufficiency in Children
There has been debate on what constitutes physiologically normal 25-hydroxyvitamin D serum levels in children. The Institute of Medicine and the American Academy of Pediatrics have recommended that 25-hydroxyvitamin D levels in children be more than 50 nmol/L. 1 The Canadian Paediatric Society has suggested that 25-hydroxyvitamin D levels be more than 75 nmol/L. 2 Given the long time course for the development of chronic health outcomes that may be related to low vitamin D levels in children, physiological indicators of vitamin D sufficiency would be helpful.
One physiological indicator of bone health is parathyroid hormone (PTH). Studies of adults have identified that PTH levels cease to decline at 25-hydroxyvitamin D levels typically more than 75 nmol/L, suggesting physiological vitamin D sufficiency. 3 In children, identifying such a plateau has been elusive. To address this, we conducted a study of healthy young children to determine whether a 25-hydroxyvitamin D plateau exists above which serum PTH is minimized.
Methods | Research ethics approval was obtained through The Hospital for Sick Children and all parents of participating children consented to study participation.
In this cross-sectional study, data were prospectively collected from healthy children 1 to 6 years of age recruited during a health maintenance physician's visit in Toronto, Ontario, Canada (latitude 43.4°N) between December 2008 and June 2011 (www.targetkids.ca). Nonfasting total 25-hydroxyvitamin D was measured using the DiaSorin LIAISON 25-hydroxyvitamin D TOTAL chemiluminescence assay with an interassay imprecision of 4.9 nmol/L (Diasorin SpA) using the DEQAS quality assessment scheme. Nonfasting PTH was measured using a Roche E170 modular electrochemiluminescence immunoassay with an interassay imprecision of 0.14 pmol/L (Hoffmann-La Roche Ltd). Laboratory tests were performed on a daily basis at the Mount Sinai Services Laboratory (www.mountsinaiservices.com).
To evaluate the relationship between 25-hydroxyvitamin D and PTH, an age-and sex-adjusted restricted cubic spline linear regression model with 3 knots was constructed. 4 Three knots were chosen because the relationship between PTH and 25-hydroxyvitamin D appeared to be fairly smooth and did not require the flexibility that additional knots provide. A plateau point was estimated by finding the root of the derivative (approximated by the standard limit definition of the derivative) of the predicted mean PTH (from the model) as a function of vitamin D. P values less than .05 (2-tailed) were considered statistically significant.
Data were analyzed using the R project for statistical computing (rms package) (www.r-project.org).
Results | Venous blood sampling was obtained from 1370 children. Mean 25-hydroxyvitamin D level was 86 nmol/L and mean PTH level was 2.67 pmol/L (Table) .
The restricted cubic spline regression model identified a nonlinear relationship between 25-hydroxyvitamin D and PTH, with a 25-hydroxyvitamin D plateau at 107 nmol/L (P < .001) ( Figure) . Age was statistically significant (P = .02) while sex was not (P = .12).
Discussion | We have identified a 25-hydroxyvitamin D plateau around 100 nmol/L above which PTH is minimized in young children. An ongoing challenge has been developing an evidence-based 25-hydroxyvitamin D threshold that supports healthy growth and development in children. A 25hydroxyvitamin D PTH plateau could be useful in setting this threshold.
To our knowledge, no study of children has had the statistical power of the present study, which may explain previous inconsistent findings. 5 Also, our study was conducted in an era in which 55% of these children were receiving a vitamin D supplement, resulting in a mean 25-hydroxyvitamin D level that may have been sufficiently high to demonstrate PTH suppression. Our data provide evidence that 25-hydroxyvitamin D levels higher than currently recommended for young children may be required to minimize PTH. Further research will need to confirm whether minimizing PTH through higher 25-hydroxyvitamin D translates into measureable improvement in health outcomes for young children. Shaded areas inside the dashed lines represent 95% confidence intervals.
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Transportation Barriers to Child Health Care Access Remain After Health Reform
The Affordable Care Act will improve access to pediatric care by expanding health insurance coverage. 1 The law has provisions to increase primary care provider supply to meet increased demand but not to improve access for families without resources to travel to health care providers. Lack of transportation is a known barrier to children attending well care visits and receiving preventive health services. 2 Nationally, regardless of insurance status, 4% of children (approximately 3 million) missed a health care appointment each year because transportation was unavailable; this includes 9% of children in families with incomes less than $50 000. Thirty-one percent later used a hospital emergency department for the health condition associated with that missed appointment. Rural areas are especially affected, having significantly fewer available public transit resources compared with metropolitan areas. Low-income households may not own a working vehicle, further limiting their options. 3 Many rural areas experience severe and protracted health professional workforce shortages. In a study of federal health professional shortage area (HPSA) designations over time, 85% of rural counties were HPSA-designated at some point during a 7-year period. One-third were designated a full-county HPSA for at least 6 of the 7 years. 4 An estimated 10.5 million US children live in an HPSA. 5
Methods | Using a newly developed and validated tool, the Health Transportation Shortage Index (HTSI), 3 we quantified and stratified the degree of risk for transportation-related access barriers for each of the 82 counties in Mississippi, which was selected as a rural state with high child poverty rates. Numeric HTSI scores (from 0-14) reflect factors associated with health care access barriers. A score of 8 or higher indicates highest risk of transportation barriers. Each county was geomapped with Geographic Information Systems software to precisely locate population centers by Census Bureau blocks, and federally qualified health centers and rural health clinics ("clinics") by longitude and latitude. Straight-line distances were calculated from population centers to the nearest clinic, including those in contiguous counties. Census Bureau data were used to ascertain county demographics.
Results | Based on its HTSI score, 55 Mississippi counties (67%) were identified as being at the highest risk for transportation barriers to health care access (mean score, 9.1; range, 8-13). All but 2 had full-county HPSA designation; 18% had populations less than 10 000 and 71% had populations between 10 000 and 30 000. All had no (13%) or limited (87%) public transit resources. The mean child population was 4709 (range, 281-9103); mean child poverty rate was 31.8% and uninsured rate was 11.8%. In 78% of these counties, the most populous areas were within 6 miles of a clinic. Mean distances from outlying population centers to clinics ranged from 6 to 14 miles.
Discussion | These results suggest that for most families in this very rural state with high child poverty rates and health workforce shortages, nonemergency medical transportation to facilitate child health care access would involve transports within a relatively narrow radius from a clinic. Additional planning would be needed to assist residents of outlying areas. While there are costs associated with the development of new transportation services, these could be offset over time by savings associated with reduced emergency department use. In a 2005 study done for the Transportation Research Board of the Na-
